Amber List

OMCLOmnicell, Inc.

Healthcare · Health Information Services · small-cap ($2.0B)
-35.5%
from rolling 252-day high of $55.00 set 2026-01-13 · 219d ago
Current
$35.50
Decline depth
-35.5%
Decline σ
5.7σ
TFC
1/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$OMCL has been tracked since 2026-03-01. It was down 25.0% from its 52-week high then — now down -35.5%.

That's 10.3 percentage points deeper than the day it joined. It bottomed 41.2% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

OMCL qualifies for the Amber List on decline depth.

Decline depth
-35.5%
From rolling 252-day high of $55.00, 219d ago. Past the 30% Amber threshold.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
5.7σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.57% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about OMCL.

OMCL qualifies for the Amber List on decline depth — down -35.5% from its rolling 252-day high.

Cross-confirmation: decline sigma also reads 5.7σ over 20 bars.

Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 2D (red).

Earnings on file: 2026-07-30. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about OMCL

What people ask.

Why is OMCL on Broken Stocks?

OMCL qualifies for the Amber List on decline depth. It is down -35.5% from its rolling 252-day high of $55.00, set on 2026-01-13 — 219d ago.

Is OMCL a falling knife?

Not by the strict technical definition. OMCL is down -35.5% from its 52-week high, but that high was set 219d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. OMCL is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is OMCL a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is OMCL trading inside its 52-week range?

At $35.50, OMCL sits 26.4% of the way from its 52-week low ($28.51) to its 52-week high ($55.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has OMCL been declining?

The current 35.5% decline accrued over 219d, which annualizes to roughly -59.2% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does OMCL compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 34 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — OMCL's decline is shallower than the sector median.

Does OMCL's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-07-30) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.